Previous studies have demonstrated that the product of the Interferon stimulated gene Ch25h, 25-Hydroxycholestrol, provides an immediate and rapid mechanism for down-regulating sterol biosynthesis, through the inhibition of Hmgcr gene expression and proteolytic degradation of HMGCR protein. Further studies provide evidence that inhibition of the sterol biosynthesis pathway by 25-HC has broad antiviral effects. In this study, Influenza A virus (IAV) replication was inhibited in cells treated with Fluvastatin or where Hmgcr expression was inhibited with an siRNA. Treatment of A549 cells with 25-HC however, resulted in a 2-fold enhancement of IAV replication despite the fact that 25-HC promotes the proteolytic degradation of HMGCR. A549 cells infected with IAV revealed a rapid loss of HMGCR protein, a reduction in Hmgcr gene expression as well as an increase in the expression of Ch25h, that were all independent of the IFN pathway.
Importance
Cholesterol, a lipid, is mainly produced by the liver or obtained from everyday foods. It is an essential element of the structure of cells and is vital for maintaining the normal function of human body. In cells, cholesterol can be oxidised to oxysterols by biological catalysts, known as enzymes. Certain oxysterols have recently emerged as important elements in the immune response to microorganisms. This project studied a key enzyme, which is a component of the cholesterol metabolism, known as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR). A set of experiments were designed and performed to study the behaviour of HMGCR following viral infections. This study lays the foundation for re-building a map of cholesterol metabolism and the immune response to viral infection. It will be useful for understanding the importance of cholesterol metabolism in infection and exploring novel antiviral strategies.
Introduction
The sterol metabolism pathway is an intrinsic component of the host defence against infection and has been shown that viral infection or the treatment of murine macrophages with type I or II interferon (IFN) down-regulates the whole sterol biosynthesis pathway [1] . In macrophages and dendritic cells (DCs) viral infection or IFN treatment induces the expression of an interferon stimulated gene, cholesterol 25-hydroxylase (Ch25h), via Toll-like receptor (TLR) induced signalling processing [2, 3] .
Ch25h catalyses the synthesis of 25-hydroxycholesterol (25-HC), which interacts with the insulin-induced gene proteins (INSIGs). INSIGs retain Sterol Regulatory Element Binding Protein 2 (SREBP2) and the cholesterol-sensing protein SREBP Cleavage-Activating Protein (SCAP) in the ER, suppressing the SREBP pathway [4] . Moreover, 25-HC also induces the ubiquitination and proteasomal degradation of HMGCR, blocking sterol biosynthesis, via SREBP-dependent and SREBPindependent mechanisms [5] [6] [7] . However, current data indicate that 25-HC does not play a major role in cholesterol homeostasis but instead has immune modulatory functions [3, 8, 9] . 25 -HC has antiviral activity against several enveloped viruses by blocking viral entry by directly modifying membranes to inhibit membrane fusions [10] . It also has effects against non-enveloped viruses, including human papillomavirus-16 (HPV-16), human rotavirus (HRoV), and human rhinovirus (HRhV) [11] . 25-HC has also been shown to inhibit differentiation of human monocytes [12] , reduce IgA production [13] and alter inflammatory responses [9, 14] . Thus 25-HC is an important component of the IFN-mediated innate immune response to infection but its various roles in immune defence are not completely understood.
In this study, we investigated the replication of Influenza A virus (IAV) in human lung epithelial A549 cells in response to inhibition of the sterol biosynthesis pathway and further examine the expression of both Hmgcr and Ch25h in response to IAV infection or IFN stimulation in A549 cells and murine BMDMs. All cultures are routinely tested for mycoplasma and endotoxin levels.
Cell culture media

Viruses
Murine cytomegalovirus (MCMV) has been previously described [ 
qRT-PCR data analysis
The MxPro qPCR software (Stratagene, USA) can be used to analyse the qRT-PCR data. Alternatively, Ct values can be exported from the software and Livak method (also known as Delta Delta CT method) [16] can be used to analyse the qRT-PCR results, which is shown below:
Control/group) − CT(Reference/gene, Control/group))(CT(Target/gene, Treated/group) − CT(Reference/gene, Treated/group))
Thereafter, the ratio of normalised target gene in treated groups relative to that in control groups can be calculated using:
siRNA transfection
DharmaFECT 1 Transfection Reagent (Thermo Scientific, UK) was used for siRNA transfection. Experiments were performed according to manufacturer's instructions. siRNAs are listed in Appendix Table 3 .
Western blot analysis
Cells were seeded in 24-well plates. After treatments, cells were lysed directly in wells by adding 100 µl of RIPA lysis buffer (9806, Cell Signaling) supplemented with protease cocktail (cOmplete Protease Inhibitor Cocktail Tablets, Roche) and Table 4 .
Preparation of HMGCR monoclonal antibody
A9 hybridoma was purchased from ATCC (CRL1811). Cells were recovered immediately and grown in medium C. In order to prepare HMGCR monoclonal antibody, cells were centrifuged and re-suspended in DMEM supplemented with 2.5% (v/v) FBS plus 0.3 mg/ml L-glu or Gibco Hybridoma-SFM (12045076, Life Technologies, UK). 20 ml of 2x10 5 cells/ml were transferred to a 75 ml flask. Cells were then kept growing in Hybridoma-SFM until more than 95% cells were dead.
The supernatant was collected, aliquoted and frozen at -20 • C. Western blot was then performed to determine the optimal dilution factor of the HMGCR monoclonal (A9) antibody.
Results
Replication of influenza A virus in response to HMGCR expression levels.
Previous studies indicate that during virus infection 25-HC provides an immediate and rapid mechanism for down-regulating sterol biosynthesis, which involves a negative feedback regulation of the sterol biosynthesis pathway and the proteolytic degradation of HMGCR via the IFN signalling pathway [3, 7] . In addition to the critical role in manipulating sterol biosynthesis, HMGCR is also a target for 25-HC associated IFN-mediated host defence against viral infection. However, it remains unknown whether HMGCR is the only target of 25-HC associated IFN-mediated innate immune response and whether this immune response broadly exists in host defence against infection. Experiments were performed to investigate whether 25-HC inhibits Influenza A virus (IAV) infection through the IFN-mediated innate immune response. Figure 1A Ethanol was used as a negative control. B. A549 cells were infected with IAV at a MOI of 0.1 in medium I for one hour. Virus was then removed and cells were treated with 0.4 µM, 2 µM and 10 µM of fluvastatin or 25-HC in medium I, respectively. Supernatant was collected at 24-hour postinfection. A plaque assay was performed to determine virus titres. Data are ± SEM (n = 3 biological replicates). C. A549 cells were transfected with siRNA Hmgcr for 72 hours in medium E. One group of cells were then harvested for western blot. Another group was infected with IAV at a MOI of 0.1 in medium I for another 24 hours. A plaque assay was performed to determine virus titres at 24hour post-infection. Risc free acts as a negative control. Data are ± SEM (n = 8 technical replicates). D. Western blot was carried out to validate the HMGCR protein levels. β-actin was used as a loading control. C-1 HMGCR antibody was used for protein detection. IAV infection leads to a reduction in Hmgcr gene expression and HMGCR protein abundance.
IAV infection leads to a reduction in Hmgcr gene expression and HMGCR protein abundance
To investigate whether IAV infection down-regulates HMGCR gene expression and endogenous protein levels, A549 cells were treated and infected as indicated in Figure 2 . A low concentration of mevastatin (0.01 µM) was used to allow for an increased dynamic range for measuring levels of HMGCR [7] . Figure 2 shows that whilst a low concentration of mevastatin strongly induced the biosynthesis of HMGCR, viral infection resulted in dramatic reduction in HMGCR protein levels ( Figure 2A and B) . In contrast, Hmgcr gene expression levels were moderately increased by mevastatin treatment in both uninfected and infected groups. A dramatic reduction in Hmgcr gene expression following IAV infection was observed at 24-hour post-infection ( Figure 2C ). In addition, viral infection induced Ch25h gene expression, which reached a peak at 8-hour post-infection and then decreased ( Figure 2D ). Taken together, IAV infection leads to a reduction in Hmgcr gene expression at late times, whereas the level of HMGCR protein quickly and dramatically dropped following infection. These data suggest that at early times the reduction in HMGCR abundance was mainly due to protein degradation rather than transcriptional down-regulation.
Figure 2. Time course study of HMGCR protein levels with IAV infection in A549 cells. A549
cells were pre-treated with medium E overnight. The next day, cells were infected with IAV at a MOI of 2 in medium E. Cells were harvested at indicated time points (post-treatment). A. Western blot was performed to determine HMGCR and NP protein levels. C-1 HMGCR antibody was used. Tubulin was used as the loading control. B. Intensity values of HMGCR to tubulin were calculated. C. qRT-PCR was used to quantify Hmgcr gene expression levels. D. Quantification of Ch25h gene expression levels. Bars present ± SEM (n = 3 technical replicates). U: uninfected; I: infected.
Is the reduction of HMGCR mediated by newly synthesised
25-HC following viral infection?
Wild-type and Ch25h -/murine BMDMs were infected with IAV and HMGCR protein levels were measured at indicated time points. Cells were pre-treated with lipoprotein-deficient medium to increase the level of HMGCR protein. The basal level of HMGCR in Ch25h -/-BMDMs is high enough to be detected under mevastatin-free conditions.
In wild-type BMDMs IAV infection greatly decreased HMGCR protein levels beginning at 3 hours post-infection ( Figure 3A) . In Ch25h -/-BMDMs the decrease of HMGCR was first observed at 8 hours post-infection ( Figure 3B ). The decrease of HMGCR protein level is delayed in Ch25h -/-BMDMs, suggesting that the newly synthesised 25-HC is most likely responsible for the reduction of HMGCR after infection at early time points (< 5 hours). However, the decrease after 8 hours postinfection cannot be caused by the action of 25-HC, since this was also observed in Ch25h -/-BMDMs. These data support a role for both 25HC dependent and independent mechanisms for the loss of HMGCR abundance in response to IAV infection in human cells.
Figure 3. Time course study of HMGCR protein levels with IAV infection in wild-type and
Ch25h -/-BMDMs. A. Wild-type BMDMs were pre-treated with medium G overnight and then infected with influenza virus at a MOI of 2 in medium G. Cells were harvested at indicated time points (post-treatment). Western blot was performed to determine HMGCR and NP protein levels in wild-type BMDMs. β-actin is the loading control. C-1 HMGCR antibody was used. B. Ch25h -/-BMDMs were infected with influenza virus at a MOI of 1 in medium F. Samples were collected for western blot. C-1 HMGCR antibody was utilized for HMGCR detection. β-actin is the loading control. U: uninfected; I: infected.
Is the degradation of HMGCR induced by IAV infection dependent on the IFN pathway?
The above experiments indicate that 25-HC is not exclusively responsible for the down-regulation of HMGCR during viral infection. Further experiments were then performed to study whether the degradation of HMGCR induced by IAV infection is dependent on the IFN pathway in human cells. A549 cells were treated with IFNα or IFN-γ. Figure 4A and C show that, in contrast to virus infection and 25-HC treatments which dramatically reduced HMGCR protein levels, treatment with IFNα or IFN-γ only modestly reduced HMGCR protein levels. This contrasts with the treatment of murine BMDMs with IFN-γ that leads to a dramatic reduction in HMGCR levels ( Figure 4F ). In order to validate this result, an A549/PIV5-V cell line, whose IFN signalling pathway is blocked by targeting the STAT1 for proteasome-mediated degradation [17] , was infected with IAV ( Figure 4E ). 4 Discussion 25-HC shows antiviral effects on a wide range of viruses by inhibiting different steps during viral infection, such as blocking viral entry and inhibiting the viral replicative cycle [3, [19] [20] [21] . In this study we show that 25-HC promotes the replication of IAV in a human lung epithelial cell line (A549) (Figure 1 ) in a dose dependent manner (> 1 µM). These results conflict with previously published data showing that IAV replication is inhibited by 25-HC in other cells such as MDCK (Canine kidney) and Murine lung epithelial cells [9] . Specifically targeting the sterol biosynthesis pathway through the use of statins or siRNAs directed against HMGCR proved to be antiviral, suggesting that the pro-viral effects of 25-HC must be due to the influence on other pathways or processes. For example, 25-HC has a role in altering cell inflammatory responses [9] and affecting inflammasome activity [14] . It could be speculated that 25-HC also influences the expression of viral restriction factors.
The RNAi mediated knockdown of HMGCR protein levels and pharmaceutical inhibition of HMGCR activity down-regulates viral activity ( Figure 1 ) and have the potential to protect hosts from viral infection [1, [22] [23] [24] [25] . Moreover, the inhibition of HMGCR increases the expression of interferon-responsive genes [26] . It has been reported that the changes in the metabolic flux of the sterol biosynthesis pathway elicit a type I IFN response mediated by STING (stimulator of interferon genes) [27] . In Murine models at least, the IFN response down-regulates sterol biosynthesis via increasing the biosynthesis of 25-HC, which also enhances the efflux of sterols, and down-regulation of the sterol biosynthesis pathway results in the up-regulation of the type I IFN response [27] . A recent paper shows that the anti-dengue virus properties of statins may associate with the down-regulation of the expression of cellular immune and pro-inflammatory response related genes, which is independent of cholesterol levels [28] . These studies suggest that HMGCR plays a role in the hosts' response to viral infection. Based on these findings, we have further investigated the relationship between HMGCR and the expression of 25-HC in response to viral infection. Figure 2 and Figure 3 show that IAV infection down-regulated HMGCR protein levels. However, at late times (> 8 hours) the down-regulation of HMGCR observed in Ch25h -/-BMDMs suggests that this reduction is mediated through 25-HC independent mechanisms (Figure 3) .
Moreover, Figure 4 shows that in human A549 cells, HMGCR down-regulation is IFN independent, as the reduction of HMGCR during IAV infection occurred in STAT1-deficient cells (Figure 4 ). Furthermore, we show that IAV infection 
